Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas

• Garima Singhal,

  Affiliation Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• ffolliott Martin Fisher,

  Affiliation Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• Melissa J. Chee,

  Affiliation Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• Tze Guan Tan,

  Affiliation Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, 02215, United States of America

  ⨯
• Abdelfattah El Ouaamari,

  Affiliation Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• Andrew C. Adams,

  Affiliation Lilly Research Laboratories, Diabetes Research, Indianapolis, Indiana, 46225, United States of America

  ⨯
• Robert Najarian,

  Affiliation Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, 02215, United States of America

  ⨯
• Rohit N. Kulkarni,

  Affiliation Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• Christophe Benoist,

  Affiliation Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, 02215, United States of America

  ⨯
• Jeffrey S. Flier,

  Affiliation Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States of America

  ⨯
• Eleftheria Maratos-Flier

  * E-mail: emaratos@bidmc.harvard.edu

  Affiliation Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States of America

  ⨯